Posted by admin on Jul 15th, 2022
Hennion & Walsh Asset Management Inc. purchased a new stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Get Rating) during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 6,856 shares of the medical instruments supplier’s stock, valued at approximately $337,000.
Several other large investors have also recently bought and sold shares of XRAY. Nordea Investment Management AB raised its position in shares of DENTSPLY SIRONA by 97.0% in the fourth quarter. Nordea Investment Management AB now owns 288,533 shares of the medical instruments supplier’s stock valued at $16,256,000 after buying an additional 142,102 shares during the last quarter. Carnegie Capital Asset Management LLC acquired a new position in shares of DENTSPLY SIRONA in the fourth quarter valued at approximately $248,000. Wedge Capital Management L L P NC raised its position in shares of DENTSPLY SIRONA by 30.8% in the fourth quarter. Wedge Capital Management L L P NC now owns 626,935 shares of the medical instruments supplier’s stock valued at $34,977,000 after buying an additional 147,596 shares during the last quarter. National Bank of Canada FI acquired a new position in shares of DENTSPLY SIRONA in the fourth quarter valued at approximately $55,000. Finally, New York State Teachers Retirement System increased its position in DENTSPLY SIRONA by 0.3% during the fourth quarter. New York State Teachers Retirement System now owns 240,672 shares of the medical instruments supplier’s stock worth $13,427,000 after purchasing an additional 736 shares during the last quarter. 94.79% of the stock is owned by institutional investors and hedge funds.
In other news, Director Eric Brandt sold 6,900 shares of the company’s stock in a transaction on Tuesday, May 3rd. The shares were sold at an average price of $39.71, for a total value of $273,999.00. Following the completion of the transaction, the director now directly owns 35,155 shares in the company, valued at $1,396,005.05. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 0.76% of the stock is currently owned by corporate insiders.
DENTSPLY SIRONA stock opened at $34.20 on Friday. DENTSPLY SIRONA Inc. has a 52-week low of $33.78 and a 52-week high of $66.98. The firm has a fifty day moving average of $37.47 and a 200-day moving average of $46.29. The firm has a market capitalization of $7.37 billion, a P/E ratio of 20.24 and a beta of 0.94. The company has a quick ratio of 1.03, a current ratio of 1.45 and a debt-to-equity ratio of 0.38.
DENTSPLY SIRONA (NASDAQ:XRAY – Get Rating) last announced its earnings results on Tuesday, May 10th. The medical instruments supplier reported $0.52 earnings per share for the quarter, beating the consensus estimate of $0.50 by $0.02. The business had revenue of $9.67 billion during the quarter, compared to the consensus estimate of $982.05 million. DENTSPLY SIRONA had a net margin of 8.81% and a return on equity of 11.63%. The business’s quarterly revenue was up 841.1% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.72 earnings per share. On average, research analysts expect that DENTSPLY SIRONA Inc. will post 2.42 EPS for the current fiscal year.
The company also recently announced a quarterly dividend, which was paid on Friday, July 8th. Stockholders of record on Friday, June 24th were paid a $0.125 dividend. The ex-dividend date was Thursday, June 23rd. This represents a $0.50 annualized dividend and a dividend yield of 1.46%. DENTSPLY SIRONA’s dividend payout ratio (DPR) is presently 29.59%.
XRAY has been the subject of several research analyst reports. Robert W. Baird lowered shares of DENTSPLY SIRONA from an “outperform” rating to a “neutral” rating and dropped their price target for the stock from $67.00 to $48.00 in a research report on Tuesday, April 19th. HC Wainwright dropped their price target on shares of DENTSPLY SIRONA from $58.00 to $48.00 and set a “hold” rating for the company in a research report on Friday, April 22nd. StockNews.com lowered shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a research report on Wednesday. Piper Sandler dropped their price target on shares of DENTSPLY SIRONA from $41.00 to $38.00 in a research report on Monday. Finally, Barrington Research dropped their price target on shares of DENTSPLY SIRONA from $53.00 to $51.00 in a research report on Wednesday, May 11th. Seven equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. According to MarketBeat, DENTSPLY SIRONA currently has an average rating of “Hold” and an average target price of $49.67.
About DENTSPLY SIRONA (Get Rating)
DENTSPLY SIRONA Inc designs, develops, manufactures, distributes, and sells various dental products and technologies for professional dental market worldwide. It offers dental equipment, including treatment centers, imaging equipment, motorized dental handpieces, and other instruments; imaging equipment; treatment centers comprising basic dentist chairs, sophisticated chair-based units with integrated diagnostic, hygiene and ergonomic functionalities, and specialist centers; and lab equipment, such as amalgamators, mixing machines, and porcelain furnaces.
Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Get Rating).
Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.
Hennion & Walsh Asset Management Inc. Sells 937 Shares of Dropbox, Inc. (NASDAQ:DBX)
15,395 Shares in Waterstone Financial, Inc. (NASDAQ:WSBF) Bought by Hennion & Walsh Asset Management Inc.